189 related articles for article (PubMed ID: 33097662)
1. PtdIns(3,4,5)P
Srijakotre N; Liu HJ; Nobis M; Man J; Yip HYK; Papa A; Abud HE; Anderson KI; Welch HCE; Tiganis T; Timpson P; McLean CA; Ooms LM; Mitchell CA
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28056-28067. PubMed ID: 33097662
[TBL] [Abstract][Full Text] [Related]
2. Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.
Barrio-Real L; Benedetti LG; Engel N; Tu Y; Cho S; Sukumar S; Kazanietz MG
Breast Cancer Res; 2014 Sep; 16(5):441. PubMed ID: 25248717
[TBL] [Abstract][Full Text] [Related]
3. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.
Liu HJ; Ooms LM; Srijakotre N; Man J; Vieusseux J; Waters JE; Feng Y; Bailey CG; Rasko JE; Price JT; Mitchell CA
J Biol Chem; 2016 Aug; 291(33):17258-70. PubMed ID: 27358402
[TBL] [Abstract][Full Text] [Related]
4. P-Rex1 directly activates RhoG to regulate GPCR-driven Rac signalling and actin polarity in neutrophils.
Damoulakis G; Gambardella L; Rossman KL; Lawson CD; Anderson KE; Fukui Y; Welch HC; Der CJ; Stephens LR; Hawkins PT
J Cell Sci; 2014 Jun; 127(Pt 11):2589-600. PubMed ID: 24659802
[TBL] [Abstract][Full Text] [Related]
5. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
6. A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.
Little JL; Serzhanova V; Izumchenko E; Egleston BL; Parise E; Klein-Szanto AJ; Loudon G; Shubina M; Seo S; Kurokawa M; Ochs MF; Golemis EA
Oncogene; 2014 Jan; 33(4):411-20. PubMed ID: 23318423
[TBL] [Abstract][Full Text] [Related]
7. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.
Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM
J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis.
Qin J; Xie Y; Wang B; Hoshino M; Wolff DW; Zhao J; Scofield MA; Dowd FJ; Lin MF; Tu Y
Oncogene; 2009 Apr; 28(16):1853-63. PubMed ID: 19305425
[TBL] [Abstract][Full Text] [Related]
9. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
10. Norbin Stimulates the Catalytic Activity and Plasma Membrane Localization of the Guanine-Nucleotide Exchange Factor P-Rex1.
Pan D; Barber MA; Hornigold K; Baker MJ; Toth JM; Oxley D; Welch HC
J Biol Chem; 2016 Mar; 291(12):6359-75. PubMed ID: 26792863
[TBL] [Abstract][Full Text] [Related]
11. Loss of ASAP1 in the MMTV-PyMT model of luminal breast cancer activates AKT, accelerates tumorigenesis, and promotes metastasis.
Schreiber C; Gruber A; Roßwag S; Saraswati S; Harkins S; Thiele W; Foroushani ZH; Munding N; Schmaus A; Rothley M; Dimmler A; Tanaka M; Garvalov BK; Sleeman JP
Cancer Lett; 2022 May; 533():215600. PubMed ID: 35181478
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a P-Rex1 gene signature in breast cancer cells.
Barrio-Real L; Wertheimer E; Garg R; Abba MC; Kazanietz MG
Oncotarget; 2016 Aug; 7(32):51335-51348. PubMed ID: 27351228
[TBL] [Abstract][Full Text] [Related]
13. P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer.
Barrio-Real L; Lopez-Haber C; Casado-Medrano V; Goglia AG; Toettcher JE; Caloca MJ; Kazanietz MG
Oncotarget; 2018 Jun; 9(47):28612-28624. PubMed ID: 29983884
[TBL] [Abstract][Full Text] [Related]
14. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
Strumane K; Rygiel T; van der Valk M; Collard JG
J Cancer Res Clin Oncol; 2009 Jan; 135(1):69-80. PubMed ID: 18592271
[TBL] [Abstract][Full Text] [Related]
15. ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant Melanoma.
Ryan MB; Finn AJ; Pedone KH; Thomas NE; Der CJ; Cox AD
Mol Cancer Res; 2016 Oct; 14(10):1009-1018. PubMed ID: 27418645
[TBL] [Abstract][Full Text] [Related]
16. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
[TBL] [Abstract][Full Text] [Related]
17. The Rho guanine nucleotide exchange factor P-Rex1 as a potential drug target for cancer metastasis and inflammatory diseases.
Ye RD
Pharmacol Res; 2020 Mar; 153():104676. PubMed ID: 32006571
[TBL] [Abstract][Full Text] [Related]
18. P-REX1 amplification promotes progression of cutaneous melanoma via the PAK1/P38/MMP-2 pathway.
Wang J; Hirose H; Du G; Chong K; Kiyohara E; Witz IP; Hoon DSB
Cancer Lett; 2017 Oct; 407():66-75. PubMed ID: 28803992
[TBL] [Abstract][Full Text] [Related]
19. The P-Rex1/Rac signaling pathway as a point of convergence for HER/ErbB receptor and GPCR responses.
Kazanietz MG; Barrio-Real L; Casado-Medrano V; Baker MJ; Lopez-Haber C
Small GTPases; 2018 Jul; 9(4):297-303. PubMed ID: 27588611
[TBL] [Abstract][Full Text] [Related]
20. Rac signaling in breast cancer: a tale of GEFs and GAPs.
Wertheimer E; Gutierrez-Uzquiza A; Rosemblit C; Lopez-Haber C; Sosa MS; Kazanietz MG
Cell Signal; 2012 Feb; 24(2):353-362. PubMed ID: 21893191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]